drugset / Trial / NCT02950883

Saline Hypertonic in Preschoolers + CT

NCT02950883 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice daily for 48 weeks reduces structural lung disease as assessed by computed tomography (CT) in comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 6) with cystic fibrosis.

Timeline

Start
2015-03-24
Primary completion
2020-12-15
Completion
2021-06-25

Outcome

Met primary endpoint

paper 1·55% (1·25-1·84) in the isotonic saline group (mean difference 0·67%, 95% CI 0·26-1·08; p=0·0092) PMID 35286860 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 4 ml Inhaled
Comparator sodium chloride Unknown 4 ml Inhaled

Indications